Another week on the U.S. stock market is starting with mixed sentiment. US100 is up by about 0.2–0.3% at the start of the session, US500 stays flat, US2000 suffers decline of aprox. 0,7%.
At the moment, the market is seeing a clash between an untiring positive trend focused on technology companies and increasingly audible skeptical voices, supported by news from the Middle East.
Despite market sentiment suggesting that a peace declaration between the U.S. and Iran has effectively been signed or will be signed soon, the situation remains unclear. The ceasefire is still fragile, and the strategically important Strait of Hormuz remains closed. Just last night, CENTCOM confirmed an Iranian attack on U.S. facilities in Kuwait.
Macroeconomic data
In the U.S., ISM and PMI data from the manufacturing sector will be released.
- The market expects the producer prices index to rise to 55.3 in May.
- The main ISM manufacturing index is expected to increase to 53 points.
US100 (D1)
The index has maintained strong upward momentum since breaking out from a local low in March. RSI remains elevated, MACD is normalizing, but the EMA structure remains clearly bullish. The key resistance is the 23.6% Fibonacci retracement (~30,485), while the first support for buyers is around ~29,730. If the 23.6% Fibonacci level is broken in the near term, the next target for buyers will be the area around 31,755 points. Source: xStation5
Company news
- Software companies: Nvidia CEO Jensen Huang noted in one of his statements that the software sector is not at as much risk from AI as some may think. Strong gains can be observed across the market. Leaders include ServiceNow (NOW.US), Salesforce (CRM.US), Adobe (ADBE.US), Workday (WDAY.US), and Palantir (PLTR.US).
- Nvidia (NVDA.US), Qualcomm (QCOM.US): Qualcomm is down about 7%, Nvidia is up just under 2%, and ARM is gaining more than 13% following Nvidia’s new product presentations. Investors are expressing concerns about competition for the “Snapdragon” product line.
- Revolution Medicines (RVMD.US): The company is up about 10% after presenting research results on a new pancreatic cancer drug.
- Taylor Morrison Home Corp. (TMHC.US): The construction company is up about 20% after Berkshire Hathaway decided to purchase the company for $8.5 billion.
- IBM (IBM.US): The stock is up about 8%. Bloomberg News attributes the rise to a new video in which Donald Trump reportedly speaks positively about the company’s CEO.
BREAKING: Iran suspends negotiations🚨
Hungary Unlocks EU Funds; EUR/HUF Drops 0.5%
Daily Summary: Is the End of the War Drawing Near? (28.05.2026)
Chart of the day: GOLD lands on EMA200 as sell-off intensifies 🟡 📉 (28.05.2026)
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
